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Abstract
The skeletal muscles in Duchenne muscular dystrophy and the mdx mouse model lack functional dystrophin and undergo
repeated bouts of necrosis, regeneration, and growth. These processes have a high metabolic cost. However, the
consequences for whole body energy and protein metabolism, and on the dietary requirements for these macronutrients at
different stages of the disease, are not well-understood. This study used juvenile (4- to 5- wk-old) and adult (12- to 14-wk-
old) male dystrophic C57BL/10ScSn-mdx/J and age-matched C57BL/10ScSn/J control male mice to measure total and
resting energy expenditure, food intake, spontaneous activity, body composition, whole body protein turnover, and muscle
protein synthesis rates. In juvenile mdx mice that have extensive muscle damage, energy expenditure, muscle protein
synthesis, and whole body protein turnover rates were higher than in age-matched controls. Adaptations in food intake and
decreased activity were insufficient to meet the increased energy and protein needs of juvenile mdx mice and resulted in
stunted growth. In (non-growing) adult mdx mice with less severe dystropathology, energy expenditure, muscle protein
synthesis, and whole body protein turnover rates were also higher than in age-matched controls. Food intake was sufficient
to meet their protein and energy needs, but insufficient to result in fat deposition. These data show that dystropathology
impacts the protein and energy needs of mdx mice and that tailored dietary interventions are necessary to redress this
imbalance. If not met, the resultant imbalance blunts growth, and may limit the benefits of therapies designed to protect
and repair dystrophic muscles.
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Introduction
Duchenne muscular dystrophy (DMD) is an X-linked lethal
muscle disease that affects approximately 1 in 3500 male births
[1,2]. Mutations or deletions in the dystrophin gene compromise
the integrity of the sarcolemma-associated dystrophin-glycoprotein
complex and render dystrophin-deficient myofibers susceptible to
damage upon contraction [3,4]. Consequently, dystrophic skeletal
muscles undergo repeated bouts of myofiber necrosis, regeneration
and growth, processes with a high metabolic cost. The
dystropathology is associated with inflammation, increased intra-
cellular calcium, oxidative stress and metabolic abnormalities [5–
10]. In DMD the heart is affected somewhat later than skeletal
muscle, and results in cardiac complications that exacerbate the
disease (reviewed in [1,11]). The extent to which the heart is
affected by changes in functional demand incurred by the altered
metabolic demands is unclear. Overall, the cumulative costs of
dystropathology on whole body protein and energy metabolism
are not well-understood. Thus, the specific dietary protein and
energy requirements of DMD boys remain poorly defined. In
order to develop better guidelines for the nutritional management
of DMD boys at different disease stages, a precise understanding of
the metabolic consequences of the dystropathology and how these
change with disease progression is urgently required.
Published data are inconsistent with regard to whether there is
an increase or decrease in energy expenditure (EE) in DMD boys;
values that span the gamut, from hyper- [12–14] to hypo-
metabolic [15,16] have been reported (reviewed in [17–19]). This
discrepancy can be attributed to small sample sizes, non-
standardised protocols for both data collection and normalization,
and predominantly to the wide variation in disease severity among
individual patients. Additionally, differences in age, ambulatory
state, body composition, and ventilation contribute to variability.
Defining the metabolic consequences of the dystropathology is
further complicated by the side-effects of widely used corticoste-
roids [20].
These variables are indeed difficult to standardize in humans
and, hence, there is a need for studies in animal models. This study
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analyses the mdx (C57BL/10ScSn-mdx/J) mouse model of DMD
that has been used in many pre-clinical experiments [11,21–23].
Despite differences in the long-term consequences and severity
between mdx mice and DMD boys (that may be largely accounted
for by the much longer duration of the growth phase, lifespan, and
scale of humans [24,25]), the mdx model offers some significant
advantages. First, invasive measurements can be performed at
different ages and disease stages. Moreover, the effects of the
disease can be studied in the absence of corticosteroids or other
therapies that modify the disease or induce their own metabolic
effects. Additionally, the model provides the possibility of assessing
the consequences of both extensive and relatively low-grade
muscle degeneration and repair on whole body protein and energy
metabolism.
The severity of dystropathology varies throughout the lifespan
of the mdx mouse and amongst mdx muscles. There is a classic
sequence of cellular events in mdx muscles that has been
extensively described in the literature (reviewed in [21,23,26])
beginning at 3 wks of age; this has also been confirmed for the
mdx mice from our mouse colony [27]. An understanding of these
events was fundamental to our study design and data interpreta-
tion. In Figure 1, generated from a synthesis of observations made
in a number of laboratories (including our own), the two ages we
selected to study (juvenile and adult) are identified. In the mdx
diaphragm, the onset of myonecrosis is evident by ,2 wk of age.
Initially, it is less severe than in limb muscles, but it is sustained
and chronically results in fibrosis and later resembles more closely
the muscles of DMD boys [28–31]. The ages and muscles we have
studied follow the recommendations of numerous international
researchers and the TREAT-NMD Neuromuscular Network that
attempt to standardize pre-clinical studies in the mdx mouse
[21,23].
Although the energy requirements of resting normal skeletal
muscle are low relative to other organs in the body [32,33], it
needs to be considered that skeletal muscle constitutes about 40%
or normal body mass. When there is a muscle dystropathology,
protein turnover and ion transport, both high energy-consuming
processes, are likely to be greater than normal. Thus, whether the
enhanced activation of these processes is sufficient to increase total
EE will depend on disease severity, the extent of necrosis/
inflammation, and the proportion of regenerating and growing
myofibers. Measurements of the effects of muscle dystropathology
on EE in the mdx mouse have yielded ambiguous results. In older
mice (6 to 12 mo), two studies found no differences between the
EE of mdx and control mice [34,35]. The significance of these
studies is difficult to assess: differences in body composition were
not accounted for; total versus resting metabolic rates, an essential
first step for identifying the basis of differences in total EE, were
not distinguished [34]; measurements were performed in multiply–
housed mice and were too short to provide an accurate assessment
of energy balance [35]; combined male and female mice were
studied [34] or the gender of mice was not stated [35]. In young 4-
to 6-wk-old mdx mice, where rates of muscle necrosis and
regeneration are very high, a decrease in whole body metabolic
rate was observed and attributed to reduced physical activity;
however the energy balance data in this study do not explain the
lower weights of the younger mdx mice [34].
Altered muscle protein turnover rates have been documented in
various mdx muscles both in vivo and ex vivo [36–38]. High rates of
protein synthesis have been demonstrated in gastrocnemius mdx
muscles, but these data did not distinguish between the synthesis of
muscle-specific proteins (indicative of regenerating myofibers) and
other protein populations in muscles, such as the extracellular
matrix proteins and those of non-muscle cells. Importantly,
however, we do not know if these changes in muscle protein
metabolism are sufficient to impact whole body protein turnover,
and hence dietary protein requirements.
The current study aims to resolve the uncertainties generated by
these earlier data, and to comprehensively define how dystro-
pathology impacts protein and energy metabolism by measuring in
individual mice the numerous factors that contribute to the
variability in these parameters. This study tests the hypothesis that
the process of dystrophic muscle necrosis and regeneration incurs
significant energy costs that the organism attempts to meet by
altering voluntary EE and food intake. We further hypothesize
that when these adaptations do not counterbalance the increased
nutrient needs incurred by the dystropathology, growth and
maintenance of normal body composition become compromised.
The extensive range of measurements performed encompass: food
intake, EE, spontaneous cage activity, body composition, muscle
protein synthesis rate - for both total (TP) and the myofibrillar
protein (MP) fraction, and whole body protein turnover.
Measurements were compared for mdx and normal mice, using
juvenile 4- to 5-wk-old mdx mice during the early stages of muscle
necrosis, regeneration and growth, and adult 12- to 14-wk-old
mdx mice when myofibers exhibit a decreased, but ongoing, low
chronic level of necrosis, regeneration and growth of repaired
myofibers. Because the severity of dystropathology differs between




Adult male and female mdx (C57BL/10ScSn-mdx/J) mice and
C57BL/10ScSn/J controls (Jackson Laboratory, Bar Harbor, ME)
housed in polycarbonate cages with wood-chip bedding were
mated. On postnatal day 2, litters were standardised to 6–7 pups
per dam. At 21 d of age, male mice were individually housed in
wire bottom cages with ad libitum access to food and water. They
were then transferred to CLAMS cages (see below); measurements
were made between 28 and 33 d of age in the ‘‘juvenile’’ group.
Adult, 10-wk-old male mice were purchased or obtained from the
in-house colony and left for a minimum of 2 wk to stabilize. They
were individually housed in wire bottom cages with ad libitum
access to food and water. All measurements were performed
between 12 and 14 wk of age. An additional set of 14-wk-old
control and mdx mice was used only for EE and activity
measurements because a complete set of activity measurements
was not obtained on the first set of mice. There was no difference
in EE between the two replicates, and the data were pooled.
Animal holding rooms were maintained at 23oC with a 12 h light/
dark cycle (light from 06:00 to 18:00). Experiments were carried
out according to the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health and approved by the Baylor College of Medicine IACUC.
Body Composition
Total fat-free (FFM) and fat masses were measured by dual-
energy X-ray absorptiometry (DXA) using a PIXImus (General
Electric). Correction factors derived specifically for our instrument
were applied to fat and FFM estimates to adjust for the inherent
calibration error (http://www.bcm.edu/cnrc/mmru/piximus).
Body ‘‘length’’ was obtained from the sum of leg and spine
lengths determined from the PIXImus-generated X-ray density
image of each mouse and corrected for magnification by
comparison to an object of known dimensions measured on the
same plane as the mouse. For normalization of muscle weights,
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dissected tibia and femur lengths were measured with Vernier
callipers.
Food Consumption
Mice were fed a semi-purified diet based on AIN93G (200 g
casein/kg; 70 g soybean oil/kg; metabolizable energy density
3640 kcal/kg; Research Diets). Daily food intakes (averaged over a
minimum of 3 d) were measured before and during EE
measurements. Food intakes were determined from the change
in weight of food cups, corrected for spillage. Food intake during
the EE measurements used the automated in-cage feeding
assembly of the CLAMS system (Columbus Instruments, described
at www.bcm.edu/cnrc/mmru).
Energy Expenditure
Energy expenditure was measured by indirect calorimetry using
a CLAMS Oxymax System (Columbus Instruments). Mice were
placed individually into CLAMS cages and after 48 h of
adaptation, O2 consumption and CO2 production were measured
for a further 72 h; EE was calculated using the Weir equation [39].
Concurrently, spontaneous physical activity (horizontal and
vertical movements) was monitored from the interruption of
infra-red beams projected in X and Z axes across the cage. For
both EE and activity, only data collected over the last 72 h were
analysed. The lowest values of EE over two 90-s periods were
averaged and extrapolated over 24 h to provide a measure of
resting EE.
Whole Body Phenylalanine and Tyrosine Fluxes
Whole body protein synthesis and degradation were estimated
in vivo from measurement of phenylalanine and tyrosine fluxes in a
subset of juvenile (n = 12) and adult (n = 10) mice of both strains.
Measurements were performed on conscious mice.
Infusions and sampling. On the infusion day, feed was
removed at 07:00 and after 3 h a tail vein catheter was inserted as
previously described [40]. A primed-continuous intravenous
infusion of L-[ring-3,5 2H2] tyrosine and L-[ring-
2H5] phenylal-
anine (prime: 11 and 16 mmolNkg BW21; continuous: 11 and
16 mmolNkgBW21Nh21, respectively) was administered to measure
the rates of appearance (Ra) of phenylalanine and tyrosine, and
the hydroxylation rate of phenylalanine to tyrosine [41]. Blood
was sampled after 4 h and the plasma stored at 280uC.
Analysis. Plasma phenylalanine and tyrosine isotopic enrich-
ments were determined as their O-phthaldialdehyde (OPA)
derivatives by LC MS (TSQ Quantum Ultra System, Thermo
Finnigan). Briefly, plasma proteins were precipitated and the
supernatants dried under vacuum. Residues were resuspended in
ddH2O and derivatized with OPA reagents (Agilent Technologies)
by the CTC-PAL autosampler (Leap Technologies). Isotopic
enrichments were determined by single reaction monitoring the
Figure 1. The progression of cellular events that occurs in dystrophic mdx limb muscles. (A) Time line showing the proportion of muscle
fibers undergoing necrosis and regenerative events from birth to adulthood. There is little if any necrosis in the limb muscles of mdx mice prior to
3 wk of age [29,73] when an abrupt onset of myofiber necrosis occurs [74–76]. By 4 wk of age approximately 30%–80% of the mdx muscles are
characterized by inflammation, phagocytosis of necrotic tissue and early myogenesis; the rest of the myofibers remain essentially ‘intact’ [21,73].
From 4 to 5 wk of age, myotubes form and damaged myofibers undergo regeneration [77]. In control mice myofibers are undamaged and grow by
elongation and hypertrophy. After this initial bout of necrosis and as normal growth decelerates, the necrosis abates to a persistent low level (,6%)
from 8 to 12 wk of age [21,26,75]. However, even if only 3% of adult mdx myofibers undergo necrosis every day, ,20% of the muscle tissue will be
subjected to necrosis over one week. As the cycles of necrosis and subsequent active regeneration take about 3 wk, it can be calculated that ,60%
of adult mdx myofibers at any time are actively affected by necrosis and regeneration. (B) The time course of regenerative events after a single bout
of myofiber necrosis. Within 1 d of damage, myofiber necrosis is evident histologically as fragmented sarcoplasm and the presence of inflammatory
cells. Coincidently there is activation of myoblast proliferation followed by their differentiation and fusion into myotubes 3 to 7 d later [74,78,79]. The
myotubes fuse with more myoblasts and each other over the next few days and after about 7 d, they fuse with the ends of the damaged myofibers
[80]; coincidently, inflammatory cells decrease. Subsequently, myotubes and newly repaired segments of damaged myofibers hypertrophy and
mature and may take a further 14 d [81]. Subsequently, the repaired fibers hypertrophy and undergo maturation attaining a stable adult size after
approximately 3 weeks. Regenerated myofibers are identified by the presence of central myonuclei that persist for many months.
doi:10.1371/journal.pone.0089277.g001
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transitions m/z 370 to 220 and 375 to 225 for phenylalanine, and
386 to 118, 388 to 118, and 390 to 118 for tyrosine.
Calculations. The rate of appearance of phenylalanine and
tyrosine were calculated from the isotopic dilution of the infused






where Raphe is the rate of appearance (flux) of phenylalanine (mmol
pheNkg21Nh21), iphe is the infusion rate (mmolNkg21Nh21) and Ephe is
the enrichment of phenylalanine at plateau (mpe).
The rate of conversion of phenylalanine to tyrosine (RcPhe?Tyr)









RaPhe and RaTyr are the appearance rates of phenylalanine and
tyrosine, respectively, determined from the steady state enrich-
ments of the infused tracers; EPhe and ETyr are the respective
plasma enrichments of the precursors and products (D5 phe and
D4 tyrosine, respectively).
RaPhe~PSPhezRcPhe?Tyr
In the fasted state, Raphe reflects phenylalanine released from
protein degradation which can be used either for protein synthesis
(PSPhe) or hydroxylated to tyrosine (RcPhe?Tyr). Thus, RcPhe?Tyr
represents irreversible net loss of phenylalanine and in the fasted
state measures net phenylalanine balance. To express the
phenylalanine flux in terms of protein, we assumed an average
phenylalanine content of body proteins of 4% [42,43].
Skeletal Muscle Fractional Protein Synthesis Rate
A modification of the procedure described previously was
followed [44].
In vivo tracer study and muscle collection. Briefly, food
was removed 7 h prior to the i.v. injection of a bolus flooding dose
of L-4-[3H]-phenylalanine (American Radiolabeled Chemicals) at
20 mLNkg BW21, 1.5 mmol phenylalanineNkg BW21 and
250 mCiNmouse21. After 15 min mice were euthanized by
decapitation and trunk blood collected and acidified. Supernatants
were used to estimate the specific radioactivity of blood free
phenylalanine. The gastrocnemius and plantaris complex (referred
to hereafter as gastrocnemius), quadriceps, soleus, tibialis anterior,
diaphragm, and heart were dissected on ice, frozen in liquid N2,
and stored at 280uC.
Muscle analyses. For each muscle, an aliquot of homoge-
nate was retained for measurement of TP. A second aliquot was
processed to determine the muscle free phenylalanine precursor
pool specific radioactivity, total RNA content, and L-[4-3H]
phenylalanine incorporated into the muscle TP pool during the
labelling period. The MPs were purified from the remainder of the
homogenate, and the incorporated L-[4-3H] phenylalanine
determined. Phenylalanine in acid hydrolysates of the TP and
MP fractions, and the muscle and blood supernatants were
isolated by anion exchange HPLC (AminoPac1 column, Dionex),
post-column derivatized with OPA reagent and detected with an
on-line fluorimeter. The radioactivity associated with the phenyl-
alanine peak was quantified by liquid scintillation counting
(Packard Tricarb, Perkin Elmer). The phenylalanine concentra-
tion was determined by comparing the peak areas of the samples
to that of a standard (Pierce Labs.).
Calculations. The fractional rate of protein synthesis (FSR),











where SB and SA are the specific radioactivities of phenylalanine in
the protein-bound and precursor pool, respectively; t is labelling
time in min. Blood and tissue free phenylalanine specific
radioactivity values were compared to verify tracer equilibration.
Absolute TP synthesis rates were calculated as the product of TP
FSR and TP muscle mass; absolute MP synthesis rates were not
calculated because the MP purification was not quantitative.
Protein Concentration
An aliquot of TP muscle homogenate solubilized in 0.3 M
NaOH was diluted 1:40 and protein concentration determined
using the micro BCA protein assay (Pierce Labs) with incubation
at 60uC for 30 min and bovine serum albumin as standard [45].
Total RNA
Total RNA was measured quantitatively on all muscle samples
to provide an estimate of ribosomal abundance. Total RNA was
quantified in the total protein PCA-insoluble precipitate using a
modified Schmidt-Thannhauser procedure [46].
Statistical Analysis
Data were subjected to ANOVA using the general linear model
procedure of MINITAB (MINITAB Inc., version 14.2). Data were
evaluated for main effects of genotype and age after evaluation for
interactions; post hoc testing was performed with Tukey’s method.
Values, where appropriate, are expressed as mean61 SE. To
determine if differences among some variables were attributable
simply to the difference in body size, ANCOVA was performed
using as covariates appropriate measures of body size, e.g. bone or
body lengths for body composition outcomes, or FFM and fat mass
for energy balance parameters [47], and FFM for phenylalanine
flux. When the interaction between the covariate and main effect
was significant, data within individual groups were analyzed
separately. In these instances values are presented as least square
means 6 SE mean. For all analyses, individuals performing the
work were blinded to the experimental group at the time of the
measurement.
Results
As there were significant interactions between covariates and
main effects, data were analysed for each age group separately,
and then within genotype across age.
Body Composition
Juvenile mice. Mdx mice were ,20% lighter and 10%
shorter than age-matched controls (Table 1). The weight
difference was attributable to proportional reductions in FFM
and fat mass; thus, fat as % of body weight was similar for both
groups. FFM was highly correlated to body length (r = 0.96), and
after accounting for differences in body length, the difference
between the FFM of control and mdx mice was not significant
(data not shown). Both femur and tibia were significantly shorter in
Protein Turnover and Energy Expenditure in Mdx Mice
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mdx mice and were correlated to total length (P,0.05), but with
no genotype x length interaction.
Absolute weights of all hind limb muscles were significantly
lighter in mdx mice and significantly correlated to bone length
(Figure 2). The differences in weight were no longer significant
when the variation in bone length was accounted for (inserts
Figure 2); this was also true with FFM as a covariate. However, TP
concentrations were lower in mdx than control muscles (13464
and 15163 mg/g muscle, respectively, P,0.01), so that the
average TP mass of the gastrocnemius was smaller in mdx mice in
absolute terms (Table 2; P,0.001) and also after adjusting for their
shorter tibial lengths (P,0.05). Absolute weights of heart and
diaphragm were similar for both groups (Figure 2) but after
accounting for differences in body length, both muscles were larger
in the juvenile mdx mice (inserts to Figure 2). As for hind limb
skeletal muscles, the TP concentration of mdx diaphragms was
lower than for controls (13563 and 14966 mg/g, respectively,
P,0.05). Thus, the diaphragm TP mass was similar between
genotypes in absolute terms (Table 2), although significantly
greater in mdx mice when differences in length were accounted for
(genotype x body length, P,0.05). There was no genotype
difference in heart TP concentration (15663 and 15862 mg/g,
respectively, P = 0.4); thus, heart TP mass was similar in juvenile
mdx and control mice in absolute terms (Table 2), but significantly
greater in the mdx mice when their shorter length (P,0.05) or
smaller FFM (P,0.05) are accounted for.
Adult mice. There was no difference between BW or length
of adult mdx and age-matched controls (Table 1). However, mdx
mice were significantly leaner with approximately 15% more FFM
and 65% less fat mass. Although FFM was correlated to body
length, it was higher in the mdx mice even after normalizing for
body length (P,0.001). For all hind limb muscles, both absolute
weights and weights normalized for bone length were greater in
mdx mice (Figure 2). However, due to the lower TP concentration
of mdx gastrocnemius muscle (14263 and 16362 mg/g for mdx
and control mice, respectively, P,0.001), the difference in TP
masses were marginally different after adjusting for tibial length
(P,0.06). The TP concentrations for diaphragms were 13864
and 14665 mg/g respectively (P,0.05), and the TP mass was
higher for mdx mice even after adjusting for body length. Absolute
values and height-adjusted values for heart weight, TP concen-
tration (16062 and 16262 mg/g respectively), and TP mass were
similar in adult mdx and age-matched control mice.
Juvenile vs. adult mice. The difference between juvenile
and adult mice in body weight and bone length was greater for
mdx than control mice. The greater weight gain of mdx mice was
due to FFM, as total fat mass was unchanged with age. In contrast,
the adult control mice had more than twice as much fat as juvenile
mice. The larger muscle mass of adult mdx mice accounted for
their higher FFM. At both ages muscle weights overestimated
muscle TP content.
Spontaneous Physical Activity
Juvenile mice. Total 24 h activity (Figure 3) was reduced by
,50% in juvenile mdx mice, and was mainly due to differences in
nocturnal behavior when young mdx mice performed only 20% of
the vertical and 50% of the horizontal movements of control mice.
Adult mice. Total activity was ,40% lower in adult mdx
(Figure 3) compared with control mice and was due to reduced
vertical movements at night.
Juvenile vs. adult. Total activity increased with age, and the
difference was greater for mdx mice. For both genotypes, there
was an equivalent increase with age in horizontal and vertical
activity in the light phase, and in vertical activity during the dark
phase. Nonetheless, total activity remained lower in mdx mice at
both ages.
Food Intake, EE, and Energy Balance
As the same diet was eaten by all mice, differences in energy
intakes are entirely explained by differences in daily food intake.
Estimates of food intake determined in the CLAMS system closely
replicated those measured in home cages.
Juvenile mice. Energy intake (kcal/d) was lower in mdx mice
compared with controls (P,0.001). This difference was propor-
tional to body size so that when intakes were adjusted for FFM and
fat mass, the genotype effect was no longer significant (Table 3).
Total daily EE was significantly higher in mdx mice after
accounting for differences in FFM and fat. During the dark/
active phase, EE was similar for both strains even though mdx
mice were significantly less active. During the light/resting phase,
Table 1. Measures of body size and composition of juvenile (4- to 5-wk-old) and adult (12- to 14-wk-old) mdx and control mice.
Group Juvenile Adult P
mdx Control mdx Control A6G A G
N 8 8 12 10
Body Composition
Weight (g) 16.560.7* 2160.7* 29.160.6 28.660.6 ,0.001 ,0.001 0.03
FFM (g) 14.660.4* 1860.4* 27.560.3* 23.760.4 ,0.001 ,0.001 NS
Fat (g) 1.9660.44 2.360.44 2.1660.36 4.9560.39* 0.005 0.001 ,0.001
(% BW) 11.961.2 1161.2 7.361.0* 16.861. 1* ,0.001 NS ,0.001
Lengths
Body (mm) 77.760.4* 8360.4* 96.760.3 96.360.4 ,0.001 ,0.001 ,0.001
Femur (mm) 12.660.1* 1360.1* 16.160.1*1 15.760.12 ,0.001 ,0.001 NS
Tibia (mm) 15.560.1* 1660.1* 18.360.1*1 17.960.12 ,0.001 ,0.001 NS
FFM, fat-free mass. Values are means6SE.
1n = 8;
2n = 7,
*significantly different from all groups.
doi:10.1371/journal.pone.0089277.t001
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when activity levels were similar, EE was significantly higher in
young mdx compared with controls. The lowest values for EE
invariably occurred during the resting phase, and commonly
followed a period of approximately 60 to 90 min when there was
minimal food consumption and no activity; therefore, it provides a
measure of resting EE. Like total EE, resting EE (adjusted for FFM
and fat) was higher for mdx than controls. Daily energy balance,
calculated as the difference between energy intake and EE was
significantly less positive (, 50%) in mdx compared with controls.
The average 24 h RQ was similar between genotypes suggesting
that both strains were metabolizing the same substrates.
Adult mice. Energy intake and total daily EE were both
significantly higher in mdx than controls. As in juvenile mice, the
energy intakes of mdx and control mice were similar once
differences in FFM and fat were accounted for; total daily EE,
however, remained higher in mdx mice (Table 3). EE was higher
during the dark/active phase than during the day/resting phase,
and values were similar for both genotypes despite the higher
activity level of control mice. During the light-phase when activity
levels were similar for both strains, total and resting EE was
greater for mdx mice. Net energy balance was positive in both
groups. This result is inconsistent with the cessation of growth, and
is likely due to overestimation of food intake caused by
underestimation of spillage that was greater for the adult mice.
Although there was a significant overall genotype effect on net
energy balance, this effect was small in adults compared with
juvenile mice. RQ averaged over 24 h was similar between
genotypes and higher at night.
Juvenile vs. adult. Daily energy intake and EE increased
with age in both groups proportional to the increases in metabolic
mass. The mass-adjusted 24 h EE was higher in mdx than controls
at both ages. Resting EE decreased with age in both groups,
independently of changes in metabolic mass. Average RQ
increased with age in all mice, and primarily reflected the changes
that occurred during the light/resting phase.
Whole Body Protein Turnover
FFM was included as a covariate in the data analyses to adjust
for the effect of the differences in protein pool size across groups.
Juvenile mice. The rate of phenylalanine appearance, Raphe,
a measure of whole body protein breakdown, was ,35% higher in
mdx compared with control mice (Figure 4). Because mice were
postabsorptive, phenylalanine incorporation into whole body
protein (PSphe) was lower than Raphe even though PSphe was higher
in juvenile mdx than control mice, the difference was not sufficient
to compensate for their higher protein breakdown rates. Thus, the
irreversible loss of phenylalanine, or net balance, was more
negative for juvenile mdx than for control mice.
Adult mice. In adult mdx mice, Raphe was almost 60%
higher than for controls. As for juveniles, PSphe, although also
higher in adult mdx mice, did not compensate for the differences
in Raphe. Thus, the balance was negative and greater for mdx than
control mice.
Figure 2. Muscle weights for mdx or control mice relative to bone or body lengths. Individual muscle weights of mdx (%) or control (N)
juvenile (4- to 5-wk-old) and adult (12- to 14-wk-old) mice are shown relative to the length of the bone that they subtend; diaphragm and heart are
plotted relative to body length. Lines represent the linear regression for values within each genotype (- - -, mdx; _____, control). Insets depict the Least
Square Means adjusted for bone or body length6SE at each age for each genotype; *, P,0.05 for mdx vs. control. The data demonstrate that in the
juvenile mdx mice the hind limb muscles (gastrocnemius, tibialis anterior, soleus, and quadriceps) are smaller than in controls in proportion to the
differences in bone lengths. In the adult mdx mice, the muscles are heavier than in controls regardless of bone length. The diaphragm and heart are
significantly heavier in the juvenile mdx mice despite their smaller size. By 12–14 wk of age the diaphragm in mdx mice remains relatively larger than
in controls, whereas the heart mass is proportionally similar in both groups.
doi:10.1371/journal.pone.0089277.g002
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Juvenile vs. adult mice
Absolute values for Raphe and PSphe increased with age (data not
shown), due to the increased size of the body protein pool with
age. Once adjusted for the differences in pool size (as shown in
Figure 4), both Raphe and PSphe decreased with age for both
genotypes, with no significant interaction. Balance became less
negative with age, and was always more negative for mdx than
control mice. Phenylalanine hydroxylation to tyrosine represents
an irreversible loss, and amounted to 1762% of phenylalanine
flux regardless of genotype or age (r = 0.97 for regression of
phenylalanine hydroxylation versus total flux).
Muscle Protein Synthesis (Table 2)
These measurements were made after completing the food
intake assessment, EE, and body composition measurements, by
which time the juvenile mice were 32- to 34-d-old, and adults were
close to 14-wk-old. Initially, we compared TP and MP FSR for
quadriceps and gastrocnemius muscles in a subset of juvenile and
adult, mdx and control mice. The values were similar and thus, for
the full set of mice, we performed measurements on the
gastrocnemius, the diaphragm, and heart.
Juvenile mice. FSR of both TP and MP were ,2-fold higher
in gastrocnemius and diaphragm muscles of juvenile mdx
compared with control mice; the responses were equivalent for
the two muscles (no significant muscle effect). The MPs were
synthesized at ,80% of the TP rate, and the relative contribution
of MP to TP FSR was marginally lower in gastrocnemius, but not
diaphragm, of mdx mice. For both gastrocnemius and diaphragm,
the higher FSRs in mdx mice were attributable to increases in
translational capacity (RNA/TP, an indicator of ribosomal
abundance) and translational efficiency (KRNA). The higher FSR
for mdx gastrocnemius was due to a 70% increase in translational
capacity and a 40% increase in KRNA, whereas for the diaphragm
the increases were approximately 30% and 50%, respectively.
The genotype effect on heart protein FSR was less marked than
for skeletal muscles. In mdx mice, TP FSR values were ,20%
higher than for controls and this difference was due largely to non-
myofibrillar proteins. There was no difference in translational
capacity between control and mdx mice; thus, the greater FSR is
attributable only to a higher KRNA.
Adult mice. The gastrocnemius TP FSR values of adult mdx
mice were ,2.5-fold higher than for controls and ,2-fold higher
for the MP fraction. Thus, non-myofibrillar proteins comprised a
larger proportion of the proteins synthesized in gastrocnemius
muscle of adult mdx compared with controls. The higher FSR for
mdx gastrocnemius was the result of a greater translational
capacity (40%) and KRNA (80%). Quantitative dissection of the
Table 2. Fractional protein synthesis rates of muscles from juvenile (4- to 5-wk-old) and adult (12- to 14-wk-old) mdx and control
mice.
Group Juvenile Adult P
mdx Control mdx Control A6G A G
N 8 8 8 7
Gastrocnemius
TP (mg) 11.160.6*{` 15.160.6{` 29.260.6* 24.860.6 ,0.001 ,0.001 NS
TP FSR (%/d) 31.161.2*{` 12.561.2{ 9.861.2* 3.961.3 ,0.001 ,0.001 ,0.001
MP FSR (%/d) 24.760.9*{` 10.460.9{` 6.761.0* 3.261 ,0.001 ,0.001 ,0.001
MP/TP FSR 0.860.03{ 0.8360.03` 0.6760.03* 0.8260.03 0.075 0.042 0.01
RNA/TP (mg/g) 17.760.5*{` 10.260.5{` 7.760.6* 5.360.6 ,0.001 ,0.001 ,0.001
KRNA (mg/g) 17.660.8 12.360.8 12.960.9 7.260.9 NS ,0.001 ,0.001
Diaphragm 1
TP (mg) 7.460.4{` 7.360.4{` 15.560.5* 11.260.5 ,0.001 ,0.001 ,0.001
TP FSR (%/d) 27.361.3*{` 13.761.4{ 15.761.5* 9.661.4 0.011 ,0.001 ,0.001
MP FSR (%/d) 21.560.9*{` 11.161.0{ 10.561.1 7.061 0.002 ,0.001 ,0.001
MP/TP FSR 0.7960.03 0.8260.03 0.6760.03 0.7460.03 NS 0.004 NS
RNA/TP (mg/g) 25.061.0 18.961.1 18.861.7 12.961.4 NS ,0.001 ,0.001
KRNA (mg/g) 10.960.4*
` 7.260.5 9.060.7 7.260.6 0.1 NS ,0.001
Heart
TP (mg) 14.360.5{` 14.360.5{` 19.260.5 18.260.5 NS ,0.001 NS
TP FSR (%/d) 15.160.5*{` 12.960.5{` 8.460.5 7.960.5 0.011 ,0.001 0.011
MP FSR (%/d) 13.660.5{` 12.960.5{` 8.160.5 8.060.5 NS ,0.001 NS
MP/TP FSR 0.960.02 0.9960.02 0.9760.02 1.0160.02 NS NS 0.006
RNA/TP (mg/g) 16.260.5 16.460.5 12.360.5 11.460.5 NS ,0.001 NS
KRNA (mg/g) 9.560.5*
{` 7.960.5 6.960.5 7.060.5 0.1 ,0.001 NS
TP, total protein; MP, myofibrillar protein; FSR, fractional synthesis rate. Values are means6SE.
1n = 4 per genotype for 14-wk-old mice. Where interactions are #0.1:
*significant genotype (G) effect at the same age (A);
{significant age effect for the same genotype;
`significantly different from opposite genotype at older age.
doi:10.1371/journal.pone.0089277.t002
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diaphragm was achieved for only 4 mice of each strain. All other
parameters evaluated did not differ between this sub-group of mice
and the total group. Overall TP and MP FSR values were higher
for diaphragm than for gastrocnemius, but the difference in FSRs
between genotypes was less than for gastrocnemius (64% for TP;
50% for MP). In contrast to gastrocnemius, the contribution of
MP to TP synthesized was similar for mdx and control mice. The
increase in translational capacity of the diaphragm was responsible
for the greater FSR in mdx mice. There were minor differences in
protein synthesis parameters of hearts between adult mdx and
controls. Like the gastrocnemius, a smaller proportion of the
proteins synthesized were MPs in mdx mice even though, overall,
the MPs make a larger contribution to TP synthesis rates in heart
compared with skeletal muscles.
Juvenile vs. adult. Even though FSR, translational capacity
and KRNA were significantly higher in mdx mice at both ages, by
and large, they exhibited a developmental decline that was
proportionally similar to the change that occurred in control mice.
There were some notable differences in mdx muscles: for both
gastrocnemius and diaphragm, the age-related decrease in MP
FSRs was greater in mdx than controls. For both genotypes, the
developmental decline in FSR for gastrocnemius muscle was
attributable to decreased translational capacity and KRNA. In
contrast, for the diaphragm, the differences in FSR were almost
entirely due to the decrease in translational capacity with age. The
age-related decline in heart TP FSR was greater in mdx mice
compared with controls, and reflected a return to normal values
from the accelerated values at the younger age. The difference
between genotypes in composition of proteins synthesized was
maintained. The decrease in heart FSR with age was explained
predominantly by decreased translational capacity, and a decrease
in KRNA to control values in mdx mice.
Figure 3. Activity levels over 24 h in juvenile and adult mdx
and control mice. The height of each column represents the mean
value (error bars represent 1 SE; n = 8/group) for the total activity
(measured as beam break counts) for each group of mice. Total activity
was significantly less in mdx mice at both ages, although the difference
decreased with age. The difference in activity levels occurred largely
during the dark period when mice are active. At both ages ambulatory
(horizontal movement) and rearing (vertical movement) were signifi-
cantly lower in the mdx than control mice.
doi:10.1371/journal.pone.0089277.g003
Table 3. Parameters of energy balance in juvenile (4- to 5-wk-old) and adult (12- to 14-wk-old) mdx and control mice.
Group Juvenile Adult P
mdx Control mdx Control A6G A G
N 8 8 9 12
Intake
24 h (kcal/d)1 11.060.7 11.360.4 11.760.6 10.960.4 NS NS NS
Expenditure
24 h (kcal/d)1 11.060.5 10.560.3 10.460.4 1060.3 NS NS 0.03
12 hdark (kcal/12 h)1 5.960.5 5.760.2 5.560.3 5.660.2 NS NS NS
12 hlight (kcal/12 h)1 5.160.2 4.860.1 4.960.2 4.460.1 NS 0.04 ,0.001
Resting (kcal/d)1 9.060.4 8.460.2 6.560.3 6.160.2 NS ,0.001 0.01
Balance
24 h (kcal/d) 0.4460.16* 1.0360.16 0.7460.15 0.7760.13 0.07 NS 0.05
RQ
24 h 0.9160.02 0.9260.02 ` 0.9560.01 0.9660.01 NS 0.004 NS
12 hdark 0.9760.02 0.9760.02 0.9960.02 0.9960.01 NS NS NS
12 hlight 0.8460.02 0.8760.02 ` 0.9260.02 0.9360.01 NS ,0.001 NS
EE, energy expenditure; RQ, respiratory quotient.
1Values are least square means adjusted for differences in FFM and fat mass6SE. Where interactions are #0.1:
*significant genotype effect at the same age.
doi:10.1371/journal.pone.0089277.t003
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Discussion
The impact of skeletal muscle necrosis and repair on whole
body protein and energy metabolism has not been extensively
characterized in dystrophic animals or humans. This information
is essential in order to assess if the consequences of muscular
dystrophy are of a magnitude sufficient to alter the organism’s
dietary energy and protein needs for optimal growth and function.
Additionally, such data may identify nutritional adjustments that
could mitigate disease severity, progression and/or development of
secondary complications. A further important consideration is that
unless the energy and protein needs of DMD patients are met
(which requires that they are accurately defined), the benefit of
therapeutic interventions cannot be fully realized. This study
identifies significant differences in parameters of EE and protein
turnover in mdx mice compared with age-matched controls that
had deleterious consequences for growth and body composition.
Ultimately, the manifested responses indicate that the diet
(optimized to meet the needs of normal animals) did not
accommodate the metabolic cost of the disease process in the
dystrophic mice especially in juveniles at the onset of dystropathol-
ogy.
Growth and Body Composition
FFM in a growing organism is highly correlated to stature. A
reduction in linear growth, manifested by the shorter body length
of juvenile mdx mice, primarily accounted for their smaller FFM.
Similarly, although the limb muscles in mdx mice weighed less
than in controls in absolute terms and accounted for their lower
FFM, the differences could be explained by their shorter bone
lengths. These data indicate that in the juvenile mdx mice overall
growth was blunted. A recent survey documents that from as early
as 2 years of age, steroid-naıve boys with DMD are shorter on
average than the general pediatric male population, suggesting
that the metabolic consequences of the dystropathology are similar
in both species during early postnatal life [48].
Broadly speaking, reduced growth rates can occur because of
inherent biological defects in growth mechanisms; however, the
attainment of normal adult size by the mdx mice signifies that their
capacity for growth was not inherently defective. Alternatively,
growth retardation occurs when nutrient intake is not sufficient to
support the growth, maintenance, and activity needs of the
organism; the consequences for body composition will depend also
on diet composition. The slower growth and reduced FFM
accompanied by age-appropriate levels of adiposity in juvenile
mdx mice mimics the response observed in young, growing
animals fed diets with suboptimal protein:energy ratios where
dietary protein intake is limiting relative to energy intake [49–51].
Extrapolating these findings to the juvenile mdx mouse, our data
suggest that the diet did not contain sufficient protein to support
their increased needs for maintenance and growth of FFM.
By 13 to 14 wk of age when growth had ceased, mdx mice were
the same weight as controls due to the exclusive gain of FFM. The
greater FFM was due to their greater gain in both overall body size
and skeletal muscle hypertrophy. With no gain in fat mass, the
adult mdx mice were significantly leaner than controls. A lean
body composition occurs in normal growing or adult animals fed
restricted amount of diets with high protein: energy ratios so that
their protein intake is sufficient, but energy intake is limiting [49–
51]. In these situations, dietary protein intake is sufficient to
support growth and/or maintenance needs, as well as being
oxidized for energy production to balance expenditure, but with
no excess for fat deposition. The body composition of adult mdx
mice contrasts with that of many DMD boys who develop obesity
[20]. Although differences in energy balance must contribute to
differences between mice and humans, diet composition, specif-
ically the relative protein and energy densities of diets, will also
influence body composition. The extent to which differences in
diet composition in the early stages of the disease contribute to
these diverse responses has not been addressed.
Comparison of the TP concentration of mdx and control
muscles indicates that at both ages, muscle weight overestimated
its metabolically active protein mass. In juvenile mdx the
difference is likely due to the greater hydration of dystrophic
muscles [52,53] resulting from local inflammation, myofiber
necrosis, and the higher water content of newly formed fibers
[54]. In the adult mdx muscle, when there is less active muscle
damage and greater muscle fibrosis, TP concentration was likely
underestimated by the BCA protein assay we used because it
underestimates collagen by approximately 30% when albumin is
used as a standard [45]. In mdx muscle the degree of fibrosis varies
depending on age and muscle type [31,55,56]. Fibrosis in muscles
of 4–5-wk-old mdx mice is relatively minor, and would introduce
negligible error in the estimates of TP concentration. However, by
3 to 4 mo of age the increased fibrosis might be sufficient to
account for the apparently lower TP concentration in adult mdx
muscles. The absence of genotype differences in heart TP
Figure 4. Whole body protein turnover in postabsorptive
juvenile and adult mdx and control mice. Whole body rates of
protein breakdown, synthesis, and protein balance were estimated from
rates of phenylalanine appearance and its conversion to tyrosine. At
both ages, rates of synthesis and breakdown were significantly higher
in mdx than control mice. Net balance was significantly more negative
in mdx mice and positively correlated to phenylalanine flux (r = 0.97). In
both mdx and control mice there was a decrease with age in all
parameters. Values are least square means (adjusted for FFM)6SE; n = 5
and 6/group in juvenile and adult mice, respectively.
doi:10.1371/journal.pone.0089277.g004
Protein Turnover and Energy Expenditure in Mdx Mice
PLOS ONE | www.plosone.org 9 February 2014 | Volume 9 | Issue 2 | e89277
concentration is consistent with the absence of notable mdx heart
pathology at the ages studied [57]. When extrapolated to a whole
body level, the differences in the protein content and composition
among skeletal muscles can quantitatively impact the interpreta-
tion of metabolic data and must be taken into consideration.
Food Intake and Energy Expenditure
After accounting for their smaller size, total daily EE was higher
in juvenile mdx than control mice. Because the juvenile mdx mice
did not regulate their intake to match their energy needs, their net
energy balance was lower. The imbalance between energy intake
and EE during growth explains their reduced weight gain that was
already evident by 21 d of age when mdx mice weighed 9.660.3 g
versus 11.660.4 g for controls (P,0.001); in the subsequent 9 d,
average daily weight gain was 0.8260.04 and 0.9860.02 g/d,
respectively (P,0.001). An important difference between juvenile
mdx and control mice was their higher resting EE, manifested also
in the light/resting-phase EE. In the dark/active-phase, differenc-
es in EE were less evident because the greater activity-related EE
of control mice compensated for their lower resting EE. In adult
mice, due to their larger size and higher tissue metabolic rates,
total daily EE also was elevated in mdx compared with control
mice. Unlike juvenile mdx mice, energy intake in the adult mdx
mice more closely matched daily EE, and the difference in energy
balance between genotypes was small. As for juvenile mice, the
higher EE in adult mdx mice was reflected in higher values for
resting EE during the resting-phase when activity levels were
lower. For both genotypes, total EE did not reflect the decrease
with age in resting EE most likely because the latter was opposed
by the increase in activity with age in both groups.
Variations in resting EE can arise from a number of causes
including: the proportion of fat to lean in the body; the masses of
tissues and organs with high metabolic rates (liver, gastrointestinal
tract, kidney, heart) relative to those with low metabolic rates
(normal skeletal muscle, bone, skin) [32,58]; and changes within a
tissue in the rate of cellular processes with a high metabolic cost,
such as protein turnover and ion transport. In juvenile mdx mice,
the relative amounts of fat and FFM were similar and thus the
difference in resting EE persisted after adjusting for body
composition. Although heart size was larger in mdx than control
mice, the difference was too small to contribute to differences in
resting EE [32,59]. Skeletal muscle weights were proportional to
the smaller FFM in juvenile mdx mice, but due to their lower TP
concentration, muscle protein masses were reduced. All other
factors being equal, a smaller muscle protein mass would augment
whole body resting EE, as was observed. Thus, this compositional
difference may have contributed in part to the difference in EE
between juvenile and control mdx mice. In adult mdx mice, a
decrease in resting EE would be expected on the basis of their
greater muscle mass; however, their EE was higher even after
accounting for their greater FFM. The higher resting EE in both
juvenile and adult mdx mice can be anticipated if protein turnover
and/or ion transport were elevated. The contribution of the
increase in protein turnover to EE is discussed below. With
advanced dystropathology, as in older DMD boys, increases in
muscle fat content or fibrosis may be sufficient to cancel out the
high energy cost processes and to reduce net EE. If not balanced
by an equivalent reduction in energy intake this would lead to
excess adipose accumulation and obesity.
Increased basal energy requirements can be met by increasing
food intake or by repartitioning EE, such as by reducing voluntary
activity and growth. Food intake was proportional to body mass
for all groups and, therefore, was not responsive to the higher
resting EE of the mdx mice. However, the mdx mice reduced their
nocturnal activity especially among the juvenile group. These
observations are consistent with previous studies which document
reduced general activity levels in adult mdx mice [22]. For the
juvenile mdx mice, food intake and reduced activity were
insufficient to meet energy needs. This imbalance most likely
contributed to their blunted growth. By adulthood, when the most
severe phase of muscle necrosis has subsided, adaptations in
activity and food intake were sufficient to meet energetic demands
so that growth was not impaired, but with no excess to promote fat
accumulation.
Our EE data contrast with those from a previous study that
measured metabolic rate in 4–6-wk-old mdx mice [34]. The
difference could be due to differences in ages of mice used and the
approaches for normalization of EE data. Our observation of
cardiac hypertrophy in the young mdx mice represents a classic
functional response to an increased oxygen demand of body tissues
and supports our findings of greater EE. Indeed, when we adjusted
heart mass for the variation in EE, the genotype effect was no
longer significant in juvenile mdx mice, suggesting that larger size
may be a functional adaptation. The notion that mdx mice have
higher energy needs that cannot be met by a conventional diet is
supported by the observation that fasting mdx mice aggravates
muscle necrosis [60] whereas feeding mdx mice an energetically
dense diet reduces their dystropathology without incurring
excessive weight gain [61].
Muscle and Whole Body Protein Turnover
At both ages, gastrocnemius TP and MP FSR values were ,2 to
2.5 times higher in mdx than age-matched controls, with
proportionally similar decreases with age. These data are
consistent with previous reports of high FSRs in muscles of mdx
mice [36] and DMD boys [62,63], although this has not been a
consistent finding in humans [64,65]. The change in gastrocne-
mius protein FSR with age in mdx mice can be attributed to both
the decrease that occurs with muscle maturation in intact
regenerated myofibers [66], and also the reduced proportion of
myofibers that are hypertrophying and turning over their proteins
more rapidly in the early phase of regeneration. The trends were
similar for the diaphragm, although the changes in FSR with age
were smaller than for the hind limb muscles in both mdx and
control mice. In juvenile mice the similar values for MP/TP FSR
for mdx and controls indicate that in the mdx muscle, the high
FSR of proteins was due to the synthesis of muscle proteins in
regenerating myofibers. In adult mdx mice, the difference in TP
FSR between mdx and control mice was greater than for MP FSR.
The reason for this difference is unclear; it is possible that in the
adult, the MP proteins are not impacted to the same extent as
sarcoplasmic and membrane proteins and it is the continuous need
for synthesis of the latter proteins with inherently higher turnover
rates that results in the proportionally higher TP FSR values. It is
also possible that at 3–4 mo of age the synthesis of extracellular
matrix proteins (measured in the TP sample) accelerates as
evidenced by their accumulation in the older muscles.
The effects of muscle dystropathology and age on protein
degradation can be inferred from the balance between protein
synthesis and accretion rates. Assuming that protein accretion to
8 wk of age is linear [36], we can estimate that at 4 wk of age
,80% of the gastrocnemius TP synthesized daily was degraded.
This represents ,25% and ,10% of the gastrocnemius TP mass
of juvenile mdx and control mice, respectively. In normal adults
protein mass is stable; thus, 100% of the protein synthesized daily
is degraded. This represents ,10% and 4% of muscle TP mass in
mdx and control mice, respectively. Thus, ,60% of the decline in
protein degradation rates in the mdx gastrocnemius over this time
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can be attributed to the decline in muscle dystropathology and the
remainder to the normal decrease in protein degradation that
occurs with maturation. Using similar assumptions for the
diaphragm, relative degradation rates were similar to those for
the gastrocnemius muscle in juvenile mice, but were higher in
adult mice (,16 and ,10% of muscle mass in mdx and controls,
respectively). These estimates of degradation are consistent with
differences in severity of the dystropathology of the muscles at
these ages.
At both ages, the higher FSR of mdx muscle proteins was
attributable to a greater translational capacity (dictated by
ribosomal abundance, RNA/TP) and translational efficiency
(dependent on translation initiation), and these were influenced
by muscle type and age. Translational capacity was higher in
diaphragm than gastrocnemius mdx muscles at both ages and was
largely responsible for the higher FSR of mdx diaphragms. This
response may reflect the more oxidative myofiber type composi-
tion of the diaphragm, with oxidative myofibers having a higher
ribosomal abundance and FSR than glycolytic myofibers [67,68].
The estimates of translational capacity of the gastrocnemius in
both groups of mice were similar to those reported previously [36].
The previously reported values for translational efficiency in mdx
mice also were similar to ours, although our values for the
translational efficiency for control muscles were lower. The
difference most likely reflects the difference between postprandial
[36,69] and post-absorptive FSR (our study) in normal muscles.
The ability of mdx muscle to sustain a high protein synthetic
efficiency in the post-absorptive state is remarkable because in
rapidly growing muscles translation initiation is dependent on
activation of the insulin and mTOR signaling pathways that are
less active in the post-absorptive state [70]. A possible explanation
is that sustained high protein breakdown rates in dystrophic
muscles may enable relatively high intracellular amino acids
concentrations to be maintained in the post-absorptive state. Thus,
unlike control muscles, the amino acid-induced activation of the
mTOR pathway that leads to translation initiation may be
sustained even in the postprandial state [70]. Similar findings have
been documented for other hyper-catabolic conditions [71,72].
This response is beneficial from the point of view of muscle repair,
but it will incur greater EE that will be most evident (relative to
controls) when animals are post-absorptive, as indeed we observed
in the present study.
The contribution of the higher rate of muscle protein turnover
in mdx muscle to whole body EE can be estimated using published
data for the contribution of skeletal muscle to whole body O2
consumption (30%) and the proportion of resting skeletal muscle
O2 consumption due to protein synthesis (17%) [32]. In a normal
adult animal, skeletal muscle protein synthesis will comprise ,5%
of whole body resting EE. For dystrophic mdx mice, a 2.5-fold
increase in the protein synthesis rates of all muscles would increase
the contribution of protein synthesis to skeletal muscle oxygen
consumption to approximately 33%. After accounting for differ-
ences in the muscle protein mass in the body of mdx mice at the
different ages (based on gastrocnemius TP masses), the calculated
increases in whole body resting EE attributable to higher rates of
muscle protein synthesis would be ,6 and 8% in the juvenile and
adult mdx mice, respectively. These values are compatible with the
differences we identified in resting EE.
Whole body protein synthesis and breakdown rates followed the
same trend as muscle protein, although the differences for whole
body measurements between mdx and control mice were
proportionally smaller than for muscle. This is to be anticipated
if the protein turnover rates in the remaining tissue and organs are
unaffected in mdx mice. To our knowledge, only data for the liver
have been reported, for which FSR were similar in mdx and
controls [36]. At both ages, the mdx mice were in greater negative
protein balance, with a trend for values to be more negative in the
younger mice. The negative balance represents irreversible loss of
phenylalanine, an indispensable amino acid that must be provided
by the diet to maintain protein equilibrium. The data demonstrate
that phenylalanine released from protein degradation is not
recycled with 100% efficiency in the post-absorptive state, and that
the proportion catabolized (17%) is constant regardless of age or
genotype. Thus, in mdx mice higher flux rates incur greater
irreversible loss of phenylalanine. The overall consequence for
protein requirements will depend on the metabolic fate of other
indispensable amino acids, especially those that are first-limiting in
the diet, and on the response of muscle protein turnover to feeding
in mdx mice. Nonetheless, the growth and body composition
responses observed suggest that the amino acid intake of juvenile
mdx mice was insufficient to support age-appropriate rates of
growth. Whether this dietary amino acid insufficiency also
compromises muscle repair in juvenile mice is a significant issue
to address. In adult mdx mice, in which phenylalanine flux was
lower, the irreversible losses also were less, and dietary intake was
sufficient to support enlargement of muscle mass.
These findings document the metabolic consequences of the
muscle dystropathology in mdx mice. While many of the changes
can be attributed to differences in cellular composition that result
from the age-dependent severity of dystropathology, the data also
demonstrate that there are metabolic consequences even when the
dystropathology is relatively mild. A dietary intake that does not
satisfy the altered metabolic demands of dystrophic muscle could
exacerbate the pathogenesis of the condition in addition to
blunting growth. Indeed, documentation that linear growth in
steroid-naive DMD boys is compromised from a very early age
[48], suggests that the metabolic demands of the disease has
repercussions for these patients even at a stage when muscle
function is only mildly compromised. Our observations on the
inter-relationships of growth, protein synthesis rates, energy needs,
diet, and activity levels have many implications for understanding
the basic pathology of dystrophic muscles, especially with respect
to the susceptibility to necrosis of both growing and adult
myofibers [24]. These data start to form a rational basis for
understanding the protein and energy requirements incurred by
muscle disease, as well as the design and impact of various
nutritional interventions in mdx mice and DMD boys, with the
aim of protecting dystrophic muscle from necrosis and helping to
maintain muscle mass at different stages of the disease.
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